Baptist Health Lexington Oncology Associates

Lexington, Kentucky 40503

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer

Studies at this site

• M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC) — Completed
• M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) — Stopped early
• M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC) — Completed